Sahara Petrochemicals and Sipchem to Resume Merger Talks

Sahara Petrochemicals and Sipchem plan to resume talks for a merger,...
Sahara Petrochemicals and Sipchem plan to resume talks for a merger, potentially creating a chemicals group worth some $4 billion (c) Eugene Sergeev/Shutterstock

Sahara Petrochemicals has announced that it is planning to resume discussions with Saudi International Petrochemical (Sipchem) in a move that could create a chemicals company worth nearly $4 billion.

The companies called off their proposed merger in June 2014, blaming the Kingdom’s inadequate regulatory framework for the collapse of the deal, which had progressed to an advanced stage by December 2013 when they both signed a Memorandum of Understanding. This would have seen Sipchem taking on the role of corporate parent to Sahara.

Sahara said talks could resume “in light of the recent changes in the regulatory framework”, without giving any further details. It added that it would make further announcements on relevant developments at an appropriate time.

The Zamil Group, one of Saudi Arabia’s prominent family businesses, is a significant shareholder in both Sahara Petrochemicals and Sipchem, along with the government.

Sahara Petrochemicals’ and Sipchem’s manufacturing plants are mostly based in Jubail. Sahara is focused on ethylene, PE, propylene and PP, while Sipchem produces methanol, butanediol, tetrahydrofuran and carbon monoxide as well as several acetyls products such as acetic acid/anhydride and vinyl acetate monomer (VAM).

 

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.